Key updates at ASCO GI 2022

Afsaneh Barzi, MD, PhD, City of Hope, Duarte, CA, talks on what she is most excited for at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022 (ASCO GI 2022). Dr. Barzi is particularly interested in studies on biliary cancer including the Phase III TOPAZ-1 (NCT03875235) trial, the findings of which will be discussed at ASCO GI 2022. This interview took place at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022.